NLS Pharmaceutics
NLSP
NLSP
2 hedge funds and large institutions have $752K invested in NLS Pharmaceutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
2
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$501K | |
| 2 | -$29.6K | |
| 3 | -$9.47K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.95K |
| 5 |
Renaissance Technologies
New York
|
-$4.72K |